Covered HCPCS Procedure Codes

For services on or after February 21, 2006, the following HCPCS procedure codes are covered for bariatric surgery:

43770 – Laparoscopy, surgical, gastric restrictive procedure; placement of adjustable gastric band (gastric band and subcutaneous port components).

43644 – Laparoscopy, surgical, gastric restrictive procedure; with gastric bypass and Roux-en-Y gastroenterostomy (roux limb 150 cm or less).

43645 – Laparoscopy with gastric bypass and small intestine reconstruction to limit absorption. (Do not report 43645 in conjunction with 49320, 43847.)

43845 – Gastric restrictive procedure with partial gastrectomy, pylorus-preserving duodenoileostomy and ileoieostomy (50 to 100 cm common channel) to limit absorption (biliopancreatic diversion with duodenal switch).

43846 – Gastric restrictive procedure, with gastric bypass for morbid obesity; with short limb (150 cm or less Roux-en-Y gastroenterostomy. (For greater than 150 cm, use 43847.) (For laparoscopic procedure, use 43644.)

43847 – With small intestine reconstruction to limit absorption.

43775– Laparoscopy, surgical, gastric restrictive procedure; longitudinal gastrectomy (i.e., sleeve gastrectomy) (Effective June 27, 2012, covered at contractor’s discretion.)


Bariatric Surgery for Treatment of Co-Morbid Conditions Related to Morbid Obesity

Effective for services on or after February 21, 2006, Medicare has determined that the following bariatric surgery procedures are reasonable and necessary under certain conditions for the treatment of morbid obesity. The patient must have a body-mass index (BMI) =35, have at least one co-morbidity related to obesity, and have been previously unsuccessful with medical treatment for obesity. This medical information must be documented in the patient’s medical record. In addition, the procedure must be performed at an approved facility. A list of approved facilities may be found at http://www.cms.gov/Medicare/Medicare-General-Information/MedicareApprovedFacilitie/Bariatric-Surgery.html
Effective for services performed on and after February 12, 2009, Medicare has determined that Type 2 diabetes mellitus is a co-morbidity for purposes of processing bariatric surgery claims.

Effective for dates of service on and after September 24, 2013, the Centers for Medicare & Medicaid Services (CMS) has removed the certified facility requirements for Bariatric Surgery for Treatment of Co-Morbid Conditions Related to Morbid Obesity.

Please note the additional national coverage determinations related to bariatric surgery will be consolidated and subsumed into Publication 100-03, Chapter 1, section 100.1. These include sections 40.5, 100.8, 100.11 and 100.14.

Open Roux-en-Y gastric bypass (RYGBP)

Laparoscopic Roux-en-Y gastric bypass (RYGBP)

Laparoscopic adjustable gastric banding (LAGB)

Open biliopancreatic diversion with duodenal switch (BPD/DS) or gastric reduction duodenal switch (BPD/GRDS)

Laparoscopic biliopancreatic diversion with duodenal switch (BPD/DS) or gastric reduction duodenal switch (BPD/GRDS)

Laparoscopic sleeve gastrectomy (LSG) (Effective June 27, 2012, covered at Medicare Administrative Contractor (MAC) discretion.

Non-Covered HCPCS Procedure Codes
For services on or after February 21, 2006, the following HCPCS procedure codes are non-covered for bariatric surgery:
43842 – Gastric restrictive procedure, without gastric bypass, for morbid obesity; vertical banded gastroplasty 
NOC code 43999 used to bill for:
Laparoscopic vertical banded gastroplasty
Open sleeve gastrectomy
Laparoscopic sleeve gastrectomy (for contractor non-covered instances)
Open adjustable gastric banding

Covered ICD Procedure Codes
For services on or after February 21, 2006, the following independent ICD-9/ICD-10 procedure codes are covered for bariatric surgery:
44.38 – Laparoscopic gastroenterostomy (laparoscopic Roux-en-Y), or
0D16479
Bypass Stomach to Duodenum with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
0D1647A
Bypass Stomach to Jejunum with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
0D1647B
Bypass Stomach to Ileum with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
0D1647L
Bypass Stomach to Transverse Colon with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
0D164J9
Bypass Stomach to Duodenum with Synthetic Substitute, Percutaneous Endoscopic Approach
0D164JA
Bypass Stomach to Jejunum with Synthetic Substitute, Percutaneous Endoscopic Approach
0D164JB
Bypass Stomach to Ileum with Synthetic Substitute, Percutaneous Endoscopic Approach
0D164JL
Bypass Stomach to Transverse Colon with Synthetic Substitute, Percutaneous Endoscopic Approach
0D164K9
Bypass Stomach to Duodenum with Non-autologous Tissue Substitute, Percutaneous Endoscopic Approach
0D164KA
Bypass Stomach to Jejunum with Non-autologous Tissue Substitute, Percutaneous Endoscopic Approach
0D164KB
Bypass Stomach to Ileum with Non-autologous Tissue Substitute, Percutaneous Endoscopic Approach
0D164KL
Bypass Stomach to Transverse Colon with Non-autologous Tissue Substitute, Percutaneous Endoscopic Approach
0D164Z9
Bypass Stomach to Duodenum, Percutaneous Endoscopic Approach
0D164ZA
Bypass Stomach to Jejunum, Percutaneous Endoscopic Approach
0D164ZB
Bypass Stomach to Ileum, Percutaneous Endoscopic Approach
0D164ZL
Bypass Stomach to Transverse Colon, Percutaneous Endoscopic Approach
44.39 – Other gastroenterostomy (open Roux-en-Y), or
0D16079
Bypass Stomach to Duodenum with Autologous Tissue Substitute, Open Approach
0D1607A
Bypass Stomach to Jejunum with Autologous Tissue Substitute, Open Approach
0D1607B
Bypass Stomach to Ileum with Autologous Tissue Substitute, Open Approach
0D1607L
Bypass Stomach to Transverse Colon with Autologous Tissue Substitute, Open Approach
0D160J9
Bypass Stomach to Duodenum with Synthetic Substitute, Open Approach
0D160JA
Bypass Stomach to Jejunum with Synthetic Substitute, Open Approach
0D160JB
Bypass Stomach to Ileum with Synthetic Substitute, Open Approach
0D160JL
Bypass Stomach to Transverse Colon with Synthetic Substitute, Open Approach
0D160K9
Bypass Stomach to Duodenum with Non-autologous Tissue Substitute, Open Approach
0D160KA
Bypass Stomach to Jejunum with Non-autologous Tissue Substitute, Open Approach
0D160KB
Bypass Stomach to Ileum with Non-autologous Tissue Substitute, Open Approach
0D160KL
Bypass Stomach to Transverse Colon with Non-autologous Tissue Substitute, Open Approach
0D160Z9
Bypass Stomach to Duodenum, Open Approach
0D160ZA
Bypass Stomach to Jejunum, Open Approach
0D160ZB
Bypass Stomach to Ileum, Open Approach
0D160ZL
Bypass Stomach to Transverse Colon, Open Approach
0D16879
Bypass Stomach to Duodenum with Autologous Tissue Substitute, Via Natural or Artificial Opening Endoscopic
0D1687A
Bypass Stomach to Jejunum with Autologous Tissue Substitute, Via Natural or Artificial Opening Endoscopic
0D1687B
Bypass Stomach to Ileum with Autologous Tissue Substitute, Via Natural or Artificial Opening Endoscopic
0D1687L
Bypass Stomach to Transverse Colon with Autologous Tissue Substitute, Via Natural or Artificial Opening Endoscopic
0D168J9
Bypass Stomach to Duodenum with Synthetic Substitute, Via Natural or Artificial Opening Endoscopic
0D168JA
Bypass Stomach to Jejunum with Synthetic Substitute, Via Natural or Artificial Opening Endoscopic
0D168JB
Bypass Stomach to Ileum with Synthetic Substitute, Via Natural or Artificial Opening Endoscopic
0D168JL
Bypass Stomach to Transverse Colon with Synthetic Substitute, Via
Natural or Artificial Opening Endoscopic
0D168K9
Bypass Stomach to Duodenum with Non-autologous Tissue Substitute, Via Natural or Artificial Opening Endoscopic
0D168KA
Bypass Stomach to Jejunum with Non-autologous Tissue Substitute, Via Natural or Artificial Opening Endoscopic
0D168KB
Bypass Stomach to Ileum with Non-autologous Tissue Substitute, Via Natural or Artificial Opening Endoscopic
0D168KL
Bypass Stomach to Transverse Colon with Non-autologous Tissue Substitute, Via Natural or Artificial Opening Endoscopic
0D168Z9
Bypass Stomach to Duodenum, Via Natural or Artificial Opening Endoscopic
0D168ZA
Bypass Stomach to Jejunum, Via Natural or Artificial Opening Endoscopic
0D168ZB
Bypass Stomach to Ileum, Via Natural or Artificial Opening Endoscopic
0D168ZL
Bypass Stomach to Transverse Colon, Via Natural or Artificial Opening Endoscopic
44.95 – Laparoscopic gastric restrictive procedure (laparoscopic adjustable gastric band and port insertion), or 0DV64CZ – Restriction of Stomach with Extraluminal Device, Percutaneous Endoscopic Approach
Many more

Claims Guidance for Payment

Covered Bariatric Surgery Procedures for Treatment of Co-Morbid Conditions Related to Morbid Obesity

Contractors shall process covered bariatric surgery claims as follows:

1. Identify bariatric surgery claims.

Contractors identify inpatient bariatric surgery claims by the presence of ICD-9/ICD-10 diagnosis code 278.01/E66.01as the primary diagnosis (for morbid obesity) and one of the covered ICD-9/ICD-10 procedure codes listed in §150.3.

Contractors identify practitioner bariatric surgery claims by the presence of ICD-9/ICD-10 diagnosis code 278.01/E66.01 as the primary diagnosis (for morbid obesity) and one of the covered HCPCS procedure codes listed in §150.2.

2. Perform facility certification validation for all bariatric surgery claims on a pre-pay basis up to and including date of service September 23, 2013.

A list of approved facilities are found at the link noted in section 150.1, section A, above.

3. Review bariatric surgery claims data and determine whether a pre- or post-pay sample of bariatric surgery claims need further review to assure that the beneficiary has a BMI =35 (V85.35-V85.45/Z68.35-Z68.45) (see ICD-10 equivalents above in section 150.5), and at least one co-morbidity related to obesity

The A/B MAC medical director may define the appropriate method for addressing the obesity-related co-morbid requirement.

Effective for dates of service on and after September 24, 2013, CMS has removed the certified facility requirements for Bariatric Surgery for Treatment of Co-Morbid Conditions Related to Morbid Obesity.